Akebia Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Discuss Recent Business Highlights
Rhea-AI Summary
Akebia Therapeutics (Nasdaq: AKBA) has scheduled the release of its fourth quarter and full year 2024 financial results on Thursday, March 13, 2025, before market open. The company will host a conference call at 8:00 a.m. ET on the same day to discuss the financial performance and recent business developments.
Investors and interested parties can access the conference call through a registration link, with recommended dial-in 15 minutes before the scheduled start time. A live webcast will be available through the Investors section of Akebia's website, with an online archive accessible afterward at ir.akebia.com.
Positive
- None.
Negative
- None.
News Market Reaction – AKBA
On the day this news was published, AKBA gained 3.50%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Akebia to Host Conference Call on March 13, 2025, at 8:00 a.m. ET
CAMBRIDGE, Mass., March 06, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the fourth quarter and full year ended December 31, 2024, on Thursday, March 13, 2025, prior to the open of financial markets.
Akebia will host a conference call on Thursday, March 13, 2024, at 8:00 a.m. ET to discuss its financial results and recent business highlights. To access the call, please register by clicking on this Registration Link, and you will be provided with dial in details. To avoid delays and ensure timely connection, we encourage dialing into the conference call 15 minutes ahead of the scheduled start time.
A live webcast of the conference call will be available via the Investors section of Akebia’s website at: https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia’s website at http://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
FAQ
When will Akebia Therapeutics (AKBA) release Q4 and full-year 2024 earnings?
What time is Akebia's (AKBA) Q4 2024 earnings conference call?
How can investors access Akebia's (AKBA) Q4 2024 earnings call?
Where can I find the replay of Akebia's (AKBA) Q4 2024 earnings call?
